A detailed history of Knott David M Jr transactions in Cytokinetics Inc stock. As of the latest transaction made, Knott David M Jr holds 30,000 shares of CYTK stock, worth $1.99 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
30,000
Holding current value
$1.99 Million
% of portfolio
0.91%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$33.23 - $54.96 $996,899 - $1.65 Million
30,000 New
30,000 $1.65 Million
Q1 2024

May 14, 2024

BUY
$63.75 - $108.06 $318,750 - $540,300
5,000 New
5,000 $351,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $6.25B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Knott David M Jr Portfolio

Follow Knott David M Jr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

News

Stay updated on Knott David M Jr with notifications on news.